vs
Side-by-side financial comparison of NATIONAL RESEARCH CORP (NRC) and Entrada Therapeutics, Inc. (TRDA). Click either name above to swap in a different company.
NATIONAL RESEARCH CORP is the larger business by last-quarter revenue ($35.2M vs $20.6M, roughly 1.7× Entrada Therapeutics, Inc.). NATIONAL RESEARCH CORP runs the higher net margin — 5.1% vs -84.4%, a 89.5% gap on every dollar of revenue. On growth, NATIONAL RESEARCH CORP posted the faster year-over-year revenue change (-4.6% vs -65.2%). NATIONAL RESEARCH CORP produced more free cash flow last quarter ($6.1M vs $-39.7M). Over the past eight quarters, Entrada Therapeutics, Inc.'s revenue compounded faster (6.4% CAGR vs -0.2%).
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
Entrada Therapeutics is a clinical-stage biotechnology firm developing transformative intracellular therapies for serious rare diseases and high-unmet-need disorders. Its pipeline covers neuromuscular, metabolic, and central nervous system segments, serving global patients via healthcare partnerships.
NRC vs TRDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2025
| Metric | | |
|---|---|---|
| Revenue | $35.2M | $20.6M |
| Net Profit | $1.8M | $-17.3M |
| Gross Margin | — | — |
| Operating Margin | 13.3% | -106.0% |
| Net Margin | 5.1% | -84.4% |
| Revenue YoY | -4.6% | -65.2% |
| Net Profit YoY | -72.6% | -173.8% |
| EPS (diluted) | $49.58 | $-0.42 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | — | ||
| Q3 25 | $34.6M | — | ||
| Q2 25 | $34.0M | — | ||
| Q1 25 | $33.6M | $20.6M | ||
| Q4 24 | $36.9M | $37.4M | ||
| Q3 24 | $35.8M | $19.6M | ||
| Q2 24 | $35.0M | $94.7M | ||
| Q1 24 | $35.3M | $59.1M |
| Q4 25 | $1.8M | — | ||
| Q3 25 | $4.1M | — | ||
| Q2 25 | $-106.0K | — | ||
| Q1 25 | $5.8M | $-17.3M | ||
| Q4 24 | $6.6M | $1.1M | ||
| Q3 24 | $5.7M | $-14.0M | ||
| Q2 24 | $6.2M | $55.0M | ||
| Q1 24 | $6.4M | $23.5M |
| Q4 25 | 13.3% | — | ||
| Q3 25 | 22.4% | — | ||
| Q2 25 | 4.7% | — | ||
| Q1 25 | 25.6% | -106.0% | ||
| Q4 24 | 26.0% | -15.7% | ||
| Q3 24 | 22.3% | -110.7% | ||
| Q2 24 | 25.3% | 56.4% | ||
| Q1 24 | 24.8% | 35.7% |
| Q4 25 | 5.1% | — | ||
| Q3 25 | 11.9% | — | ||
| Q2 25 | -0.3% | — | ||
| Q1 25 | 17.2% | -84.4% | ||
| Q4 24 | 17.8% | 3.0% | ||
| Q3 24 | 15.9% | -71.7% | ||
| Q2 24 | 17.6% | 58.1% | ||
| Q1 24 | 18.0% | 39.7% |
| Q4 25 | $49.58 | — | ||
| Q3 25 | $0.18 | — | ||
| Q2 25 | $-0.01 | — | ||
| Q1 25 | $0.25 | $-0.42 | ||
| Q4 24 | $0.27 | $-0.20 | ||
| Q3 24 | $0.24 | $-0.35 | ||
| Q2 24 | $0.26 | $1.55 | ||
| Q1 24 | $0.27 | $0.68 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | $67.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $14.0M | $417.3M |
| Total Assets | $134.9M | $486.5M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | — | ||
| Q3 25 | $2.2M | — | ||
| Q2 25 | $5.3M | — | ||
| Q1 25 | $2.5M | $67.8M | ||
| Q4 24 | $4.2M | $101.2M | ||
| Q3 24 | $3.5M | $78.0M | ||
| Q2 24 | $485.0K | $185.3M | ||
| Q1 24 | $1.7M | $68.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $48.7M | — | ||
| Q2 24 | $33.3M | — | ||
| Q1 24 | $35.2M | — |
| Q4 25 | $14.0M | — | ||
| Q3 25 | $14.3M | — | ||
| Q2 25 | $21.3M | — | ||
| Q1 25 | $29.7M | $417.3M | ||
| Q4 24 | $31.3M | $428.7M | ||
| Q3 24 | $34.6M | $422.4M | ||
| Q2 24 | $40.2M | $429.9M | ||
| Q1 24 | $36.9M | $269.4M |
| Q4 25 | $134.9M | — | ||
| Q3 25 | $135.7M | — | ||
| Q2 25 | $141.4M | — | ||
| Q1 25 | $135.2M | $486.5M | ||
| Q4 24 | $132.5M | $526.3M | ||
| Q3 24 | $131.8M | $554.6M | ||
| Q2 24 | $119.1M | $582.0M | ||
| Q1 24 | $120.9M | $510.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.95× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $7.2M | $-38.5M |
| Free Cash FlowOCF − Capex | $6.1M | $-39.7M |
| FCF MarginFCF / Revenue | 17.2% | -192.9% |
| Capex IntensityCapex / Revenue | 3.2% | 5.6% |
| Cash ConversionOCF / Net Profit | 3.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | $15.7M | $-58.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.2M | — | ||
| Q3 25 | $13.8M | — | ||
| Q2 25 | $-1.1M | — | ||
| Q1 25 | $6.6M | $-38.5M | ||
| Q4 24 | $6.4M | $-31.6M | ||
| Q3 24 | $9.4M | $-24.3M | ||
| Q2 24 | $6.8M | $39.8M | ||
| Q1 24 | $12.0M | $-25.5M |
| Q4 25 | $6.1M | — | ||
| Q3 25 | $10.2M | — | ||
| Q2 25 | $-4.1M | — | ||
| Q1 25 | $3.7M | $-39.7M | ||
| Q4 24 | $1.9M | $-32.2M | ||
| Q3 24 | $7.8M | $-24.9M | ||
| Q2 24 | $1.5M | $38.8M | ||
| Q1 24 | $7.9M | $-26.4M |
| Q4 25 | 17.2% | — | ||
| Q3 25 | 29.4% | — | ||
| Q2 25 | -12.2% | — | ||
| Q1 25 | 10.9% | -192.9% | ||
| Q4 24 | 5.2% | -86.2% | ||
| Q3 24 | 21.8% | -127.3% | ||
| Q2 24 | 4.3% | 41.0% | ||
| Q1 24 | 22.4% | -44.6% |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 8.8% | — | ||
| Q1 25 | 8.9% | 5.6% | ||
| Q4 24 | 12.0% | 1.7% | ||
| Q3 24 | 4.5% | 3.3% | ||
| Q2 24 | 15.0% | 1.1% | ||
| Q1 24 | 11.7% | 1.4% |
| Q4 25 | 3.99× | — | ||
| Q3 25 | 3.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.15× | — | ||
| Q4 24 | 0.97× | -27.94× | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 1.10× | 0.72× | ||
| Q1 24 | 1.89× | -1.09× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
